PHARMA GUIDE

Using DiGA Data Lawfully

GDPR & DiGAV: How to Use Patient Data Legally for Pharmaceutical Sales and R&D

Last updated: June 2024

Whitepaper cover: Using DiGA Data Lawfully

Contents

  • How pharmaceutical companies can use DiGA data
  • Legal framework for the use of DiGA data
  • What is not allowed?
  • Solution for lawful data processing

    Pharmaceutical companies benefit greatly from real-world data about the target group of their own drugs. This real-world data helps, for example, with selling medications or developing new drug products. That is why more and more pharmaceutical companies are trying to expand their portfolio to include digital products. The main goal is to use these products to generate data about their own customers, for example with DiGA.

    So how can a DiGA be used to collect data on a broad scale in order to then use it for Research & Development or the marketing of drugs?

    Laws such as the Digital Health Applications Ordinance (DiGAV) and the General Data Protection Regulation (GDPR) define a strict framework for data protection.

    In this whitepaper, we give you a clear answer to these questions.

    Exclusive Insights: Our 14-Page Insider Report

    Whitepaper "Using DiGA Data Lawfully" - Preview
    Whitepaper "Using DiGA Data Lawfully" - Preview
    Whitepaper "Using DiGA Data Lawfully" - Preview